
    
      This is a double blind, randomized, placebo controlled trial. Participants were consecutive
      patients with resistant hypertension, defined as uncontrolled BP, despite the concurrent use
      of 3 or more antihypertensive agents, including a diuretic, with adherence to treatment and
      without white coat phenomenon. All participants should have a diagnosis of at least moderate
      OSAS, defined by AHI > 15 in a portable monitoring sleep exam. Participants were assigned to
      active CPAP or sham-CPAP. The main outcome was change in 24-hour ambulatory blood pressure
      (ABP) monitoring values from baseline to two months of active CPAP or sham CPAP
    
  